Dysfunction of the Clinical Effect of Levonorgestrel Treatment of Dysfunctional Uterine Bleeding
Keywords:
Levonorgestrel, Uterine bleeding, Perimenopausal
Abstract
Objective: Study clinical curative effect of levonorgestrel treatment on perimenopausal dysfunctional uterine bleeding. Method: Selected 126 outpatient of dysfunctional uterine bleeding which hospitalize from December 2010 to December 2012 at department of gynaecology to undergo levonorgestrel treatment on the 5‒7 days of menstruation. The endometrial thickness, hemoglobin, and the PBAC score of before and 3, 6, and 12 months after placement were observed and recorded. To observation the adverse reactions after levonorgestrel treatment. Results: After treatment, the thickness of the endometrium, the amount of menstruation and the hemoglobin concentration increased in 126 patients. During the treatment, 21 patients experienced mild dizziness and nausea, but did not affect the drug use and efficacy. Conclusion: Effects of levonorgestrel on intrauterine treatment of perimenopausal dysfunctional uterine bleeding can effectively reduce the amount of menstruation and increase hemoglobin levels. It is economic, simple, less adverse reaction, and widely entrenched in clinical practice.References
1. Kong BH. Obstetrics. Beijing: Higher Education Press. 2005:384‒390.
2. Wang JL, Zou GY. Levonorgestrel releasing intrauterine system on functional disorders of uterine bleeding preliminary observation on therapeutic effect. Beijing Medical. 2009;31(6):353‒355.
3. Chen H, Peng LQ. Levonorgestrel intrauterine release system in the treatment of peri menopausal dysfunctional uterine bleeding clinical observation. China Medical Guidelines. 2011;(12):7‒16.
4. Xu XW, Yan LZ, Sun J, et al. Levonorgestrel releasing intrauterine system in treatment of obstinate dysfunction uterine bleeding clinical curative effect observation. Journal of Medical Research. 2012;41(4):92‒95.
5. Zhou Q. Levonorgestrel tablets in the treatment of functional disorders uterine bleeding clinical analysis. Chinese and Foreign Medical Research. 2013;11(4):132‒133.
6. Li N, Zhu HM. Levonorgestrel on 36 cases of observation of the curative effect of dysfunctional uterine bleeding. International Journal of Pharmaceutical Medicine. 2012;18(6):789‒792.
7. Qiao F, Jin L, Ai L, Zhang JS, et al. Norethindrone in the treatment of anovulatory functional disorders of uterine hemorrhage curative effect analysis. China Obstetrics and Gynecology Journal of clinical. 2010;11(4):57‒61.
2. Wang JL, Zou GY. Levonorgestrel releasing intrauterine system on functional disorders of uterine bleeding preliminary observation on therapeutic effect. Beijing Medical. 2009;31(6):353‒355.
3. Chen H, Peng LQ. Levonorgestrel intrauterine release system in the treatment of peri menopausal dysfunctional uterine bleeding clinical observation. China Medical Guidelines. 2011;(12):7‒16.
4. Xu XW, Yan LZ, Sun J, et al. Levonorgestrel releasing intrauterine system in treatment of obstinate dysfunction uterine bleeding clinical curative effect observation. Journal of Medical Research. 2012;41(4):92‒95.
5. Zhou Q. Levonorgestrel tablets in the treatment of functional disorders uterine bleeding clinical analysis. Chinese and Foreign Medical Research. 2013;11(4):132‒133.
6. Li N, Zhu HM. Levonorgestrel on 36 cases of observation of the curative effect of dysfunctional uterine bleeding. International Journal of Pharmaceutical Medicine. 2012;18(6):789‒792.
7. Qiao F, Jin L, Ai L, Zhang JS, et al. Norethindrone in the treatment of anovulatory functional disorders of uterine hemorrhage curative effect analysis. China Obstetrics and Gynecology Journal of clinical. 2010;11(4):57‒61.
Published
2013-08-20
Issue
Section
Original Research Article
Copyright (c) 2013 Xinhui Mi, Caixia Qin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.
